kainic acid has been researched along with Celiac Sprue in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calabrò, A; Gerace, E; Landucci, E; Mannaioni, G; Masi, A; Pellegrini-Giampietro, DE; Renzi, D; Resta, F | 1 |
1 other study(ies) available for kainic acid and Celiac Sprue
| Article | Year |
|---|---|
The gliadin peptide 31-43 exacerbates kainate neurotoxicity in epilepsy models.
Topics: Action Potentials; CA3 Region, Hippocampal; Celiac Disease; Electroencephalography; Epilepsy; Excitatory Amino Acid Agonists; Gliadin; Humans; Kainic Acid; Peptide Fragments; Transglutaminases | 2017 |